Osteoporosis is the most frequent metabolic bone disease and the one which mostly benefited from the knowledge of bone metabolism, both in terms of diagnosis and therapy. In the future, pharmacogenomics will optimize therapy response by customization on the basis of genotype, improving efficacy, and limiting the onset of side effects.
An overview of osteoporosis: from genetics to clinics / M. L. Brandi. - In: AGING CLINICAL AND EXPERIMENTAL RESEARCH. - ISSN 1594-0667. - ELETTRONICO. - 23:(2011), pp. 3-5.
An overview of osteoporosis: from genetics to clinics.
BRANDI, MARIA LUISA
2011
Abstract
Osteoporosis is the most frequent metabolic bone disease and the one which mostly benefited from the knowledge of bone metabolism, both in terms of diagnosis and therapy. In the future, pharmacogenomics will optimize therapy response by customization on the basis of genotype, improving efficacy, and limiting the onset of side effects.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
